Hypertension ,Renal atherosclerosis
Conditions
Interventions
Control group:Placebo
Sponsors
Capital Medical Development Fund
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with essential hypertension who have atherosclerotic vulnerable plaques in the renal artery.
Exclusion criteria
Exclusion criteria: Secondary hypertension, renal hypertension, congenital fibromuscular dysplasia hypertension, aortic coaccotion hypertension, aortitis induced hypertension, pheochromocytoma, Cushing's syndrome, primary aldosterone elevation induced hypertension, sleep apnea syndrome associated hypertension, hypertension caused by renal artery stenosis (i.e. patients with renal artery stenosis>50%) .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the stable state of vulnerable plaques; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ambulatory blood pressure assessment; | — |
Countries
China
Contacts
Public ContactWenli Cheng
Beijing Anzhen Hospital
Outcome results
None listed